NPY and prostate carcinoma: NPY released from nerve terminals regulates oncogenesis and therapy resistance in prostate cancer: tumor cells favored the increase in NPY-positive nerve fibers, and the inhibition of NPY promoted apoptosis in cancer cells [243].